schliessen

Filtern

 

Bibliotheken

Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells

Breast cancer patients with HER‐2 positive or estrogen receptor negative tumors have a poor prognosis because these tumors are aggressive and respond poorly to standard therapies. Histone deacetylase (HDAC) inhibitors have been shown to decreased cell survival, which suggests that HDAC inhibitors ma... Full description

Journal Title: Molecular Carcinogenesis May 2013, Vol.52(5), pp.404-411
Main Author: Yan, Guang
Other Authors: Graham, Kimmer , Lanza‐Jacoby, Susan
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0899-1987 ; E-ISSN: 1098-2744 ; DOI: 10.1002/mc.21875
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: wj10.1002/mc.21875
title: Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells
format: Article
creator:
  • Yan, Guang
  • Graham, Kimmer
  • Lanza‐Jacoby, Susan
subjects:
  • Breast Cancer
  • Curcumin
  • Histone Deacetylase Inhibitors
ispartof: Molecular Carcinogenesis, May 2013, Vol.52(5), pp.404-411
description: Breast cancer patients with HER‐2 positive or estrogen receptor negative tumors have a poor prognosis because these tumors are aggressive and respond poorly to standard therapies. Histone deacetylase (HDAC) inhibitors have been shown to decreased cell survival, which suggests that HDAC inhibitors may be developed for preventing and treating breast cancer. Curcumin has anti‐inflammatory and proapoptotic effects in cancer cells. We determined whether the HDAC inhibitor, Tricostatin A (TSA) in combination with curcumin would produce greater antiproliferative and apoptotic effects than either agent alone. Increasing the concentration of curcumin from 10 to 20 µM enhanced the growth inhibitory effects of the combination in SkBr3 and 435eB breast cancer cells, which was accompanied by decreased viability along with decreased phosphorylation of ERK and Akt. The decreased cell viability observed in SkBr3 cells when curcumin was combined with TSA led to a G0/G1 cell cycle arrest and increased p21 and p27, and decreased Cyclin D1 protein expression. The combination induced cleavage of caspase 3 and poly(ADP‐ribose) polymerase‐1, suggesting that cell death occurred by apoptosis. There were no changes in protein expression of Bcl2, Bax, or Bcl‐xL and decreased expression of p53. The combination increased protein expression of phosphorylated JNK and phosphorylated p38. Pharmacological inhibition of JNK, but not p38, attenuated the decreased viability induced by the curcumin and TSA combination. We conclude that p53 independent apoptosis induced by combining curcumin and TSA involves JNK activation. These findings provide a rationale for exploring the potential benefits of the combination of curcumin with TSA for treatment of breast cancer. © 2012 Wiley Periodicals, Inc.
language: eng
source:
identifier: ISSN: 0899-1987 ; E-ISSN: 1098-2744 ; DOI: 10.1002/mc.21875
fulltext: fulltext
issn:
  • 0899-1987
  • 08991987
  • 1098-2744
  • 10982744
url: Link


@attributes
ID1442312072
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10.1002/mc.21875
sourceidwj
recordidTN_wj10.1002/mc.21875
sourcesystemOther
pqid1326725727
galeid325427075
display
typearticle
titleCurcumin enhances the anticancer effects of trichostatin a in breast cancer cells
creatorYan, Guang ; Graham, Kimmer ; Lanza‐Jacoby, Susan
ispartofMolecular Carcinogenesis, May 2013, Vol.52(5), pp.404-411
identifier
subjectBreast Cancer ; Curcumin ; Histone Deacetylase Inhibitors
descriptionBreast cancer patients with HER‐2 positive or estrogen receptor negative tumors have a poor prognosis because these tumors are aggressive and respond poorly to standard therapies. Histone deacetylase (HDAC) inhibitors have been shown to decreased cell survival, which suggests that HDAC inhibitors may be developed for preventing and treating breast cancer. Curcumin has anti‐inflammatory and proapoptotic effects in cancer cells. We determined whether the HDAC inhibitor, Tricostatin A (TSA) in combination with curcumin would produce greater antiproliferative and apoptotic effects than either agent alone. Increasing the concentration of curcumin from 10 to 20 µM enhanced the growth inhibitory effects of the combination in SkBr3 and 435eB breast cancer cells, which was accompanied by decreased viability along with decreased phosphorylation of ERK and Akt. The decreased cell viability observed in SkBr3 cells when curcumin was combined with TSA led to a G0/G1 cell cycle arrest and increased p21 and p27, and decreased Cyclin D1 protein expression. The combination induced cleavage of caspase 3 and poly(ADP‐ribose) polymerase‐1, suggesting that cell death occurred by apoptosis. There were no changes in protein expression of Bcl2, Bax, or Bcl‐xL and decreased expression of p53. The combination increased protein expression of phosphorylated JNK and phosphorylated p38. Pharmacological inhibition of JNK, but not p38, attenuated the decreased viability induced by the curcumin and TSA combination. We conclude that p53 independent apoptosis induced by combining curcumin and TSA involves JNK activation. These findings provide a rationale for exploring the potential benefits of the combination of curcumin with TSA for treatment of breast cancer. © 2012 Wiley Periodicals, Inc.
languageeng
source
version6
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
search
creatorcontrib
0Yan, Guang
1Graham, Kimmer
2Lanza‐Jacoby, Susan
titleCurcumin enhances the anticancer effects of trichostatin a in breast cancer cells
descriptionBreast cancer patients with HER‐2 positive or estrogen receptor negative tumors have a poor prognosis because these tumors are aggressive and respond poorly to standard therapies. Histone deacetylase (HDAC) inhibitors have been shown to decreased cell survival, which suggests that HDAC inhibitors may be developed for preventing and treating breast cancer. Curcumin has anti‐inflammatory and proapoptotic effects in cancer cells. We determined whether the HDAC inhibitor, Tricostatin A (TSA) in combination with curcumin would produce greater antiproliferative and apoptotic effects than either agent alone. Increasing the concentration of curcumin from 10 to 20 µM enhanced the growth inhibitory effects of the combination in SkBr3 and 435eB breast cancer cells, which was accompanied by decreased viability along with decreased phosphorylation of ERK and Akt. The decreased cell viability observed in SkBr3 cells when curcumin was combined with TSA led to a G0/G1 cell cycle arrest and increased p21 and p27, and decreased Cyclin D1 protein expression. The combination induced cleavage of caspase 3 and poly(ADP‐ribose) polymerase‐1, suggesting that cell death occurred by apoptosis. There were no changes in protein expression of Bcl2, Bax, or Bcl‐xL and decreased expression of p53. The combination increased protein expression of phosphorylated JNK and phosphorylated p38. Pharmacological inhibition of JNK, but not p38, attenuated the decreased viability induced by the curcumin and TSA combination. We conclude that p53 independent apoptosis induced by combining curcumin and TSA involves JNK activation. These findings provide a rationale for exploring the potential benefits of the combination of curcumin with TSA for treatment of breast cancer. © 2012 Wiley Periodicals, Inc.
subject
0Breast Cancer
1Curcumin
2Histone Deacetylase Inhibitors
general
0English
1Wiley Subscription Services, Inc., A Wiley Company
210.1002/mc.21875
3Wiley Online Library
sourceidwj
recordidwj10.1002/mc.21875
issn
00899-1987
108991987
21098-2744
310982744
rsrctypearticle
creationdate2013
addtitle
0Molecular Carcinogenesis
1Mol. Carcinog.
searchscope
0wj
1wiley
scope
0wj
1wiley
lsr30VSR-Enriched:[pages, pqid, galeid]
sort
titleCurcumin enhances the anticancer effects of trichostatin a in breast cancer cells
authorYan, Guang ; Graham, Kimmer ; Lanza‐Jacoby, Susan
creationdate20130500
facets
frbrgroupid8769547176855807468
frbrtype5
languageeng
creationdate2013
topic
0Breast Cancer
1Curcumin
2Histone Deacetylase Inhibitors
collectionWiley Online Library
prefilterarticles
rsrctypearticles
creatorcontrib
0Yan, Guang
1Graham, Kimmer
2Lanza‐Jacoby, Susan
jtitleMolecular Carcinogenesis
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Yan
1Graham
2Lanza‐Jacoby
aufirst
0Guang
1Kimmer
2Susan
au
0Yan, Guang
1Graham, Kimmer
2Lanza‐Jacoby, Susan
atitleCurcumin enhances the anticancer effects of trichostatin a in breast cancer cells
jtitleMolecular Carcinogenesis
risdate201305
volume52
issue5
spage404
epage411
issn0899-1987
eissn1098-2744
genrearticle
ristypeJOUR
abstractBreast cancer patients with HER‐2 positive or estrogen receptor negative tumors have a poor prognosis because these tumors are aggressive and respond poorly to standard therapies. Histone deacetylase (HDAC) inhibitors have been shown to decreased cell survival, which suggests that HDAC inhibitors may be developed for preventing and treating breast cancer. Curcumin has anti‐inflammatory and proapoptotic effects in cancer cells. We determined whether the HDAC inhibitor, Tricostatin A (TSA) in combination with curcumin would produce greater antiproliferative and apoptotic effects than either agent alone. Increasing the concentration of curcumin from 10 to 20 µM enhanced the growth inhibitory effects of the combination in SkBr3 and 435eB breast cancer cells, which was accompanied by decreased viability along with decreased phosphorylation of ERK and Akt. The decreased cell viability observed in SkBr3 cells when curcumin was combined with TSA led to a G0/G1 cell cycle arrest and increased p21 and p27, and decreased Cyclin D1 protein expression. The combination induced cleavage of caspase 3 and poly(ADP‐ribose) polymerase‐1, suggesting that cell death occurred by apoptosis. There were no changes in protein expression of Bcl2, Bax, or Bcl‐xL and decreased expression of p53. The combination increased protein expression of phosphorylated JNK and phosphorylated p38. Pharmacological inhibition of JNK, but not p38, attenuated the decreased viability induced by the curcumin and TSA combination. We conclude that p53 independent apoptosis induced by combining curcumin and TSA involves JNK activation. These findings provide a rationale for exploring the potential benefits of the combination of curcumin with TSA for treatment of breast cancer. © 2012 Wiley Periodicals, Inc.
copHoboken
pubWiley Subscription Services, Inc., A Wiley Company
doi10.1002/mc.21875
pages404-411
date2013-05